Opus Genetics (IRD) Other financing activities (2011 - 2026)
Opus Genetics' (IRD) quarterly Other financing activities came in at $738000.0 in Q1 2026, up 14660.0% year-on-year from N/an in Q1 2025, and down 6.94% on a QoQ basis from $793000.0 in Q4 2025.
Opus Genetics (IRD) Other financing activities (2011 - 2026) Analysis & Trends
Opus Genetics (IRD) has 11 years of Other financing activities data on file, last reported at $738000.0 in Q1 2026.
- On a quarterly basis, Other financing activities rose 14660.0% year-over-year to $738000.0 in Q1 2026; TTM through Mar 2026 was $1.6 million, a 30960.0% increase from a year earlier, with the FY2025 full-year figure at $820000.0, changed N/A from the prior year.
- Other financing activities for Q1 2026 stood at $738000.0, down from $793000.0 in the prior quarter.
- Over the last five years, Other financing activities for IRD reached as high as $793000.0 in Q4 2025 and fell as low as $5000.0 in Q1 2025.
- Historically, Other financing activities has averaged $269166.7 across 4 years, with a median of $28500.0 in 2022.
- Across the five-year window, Other financing activities surged 170.0% in 2022 and jumped 14660.0% in 2026, its largest moves.
- Year by year, Other financing activities stood at $27000.0 in 2022, then advanced by 11.11% to $30000.0 in 2023, then jumped by 2543.33% to $793000.0 in 2025, then slipped by 6.94% to $738000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $738000.0 in Q1 2026, $793000.0 in Q4 2025, and $22000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Opus Genetics | 3.27 Mn | -56.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 738,000.00 |
| Mar 31, 2026 | 738,000.00 |
| Dec 31, 2025 | 793,000.00 |
| Dec 31, 2025 | 793,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Mar 31, 2022 | 27,000.00 |
| Mar 31, 2022 | 27,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 76,000.00 |
| Sep 30, 2021 | 76,000.00 |
| Mar 31, 2021 | 10,000.00 |
| Mar 31, 2021 | 10,000.00 |
| Dec 31, 2020 | 58,000.00 |
| Dec 31, 2020 | 58,000.00 |